Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics

Sponsor
Centers for Disease Control and Prevention (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00737646
Collaborator
(none)
5,066
3
3
29
1688.7
58.2

Study Details

Study Description

Brief Summary

This study is a three-arm randomized controlled trial to implement and evaluate the relative effects of: 1) clinic-focused intervention; 2) combined patient- and clinic-focused intervention, and 3) usual care on the provision of colorectal cancer (CRC) screening in primary care clinics. The study will also examine the relative effects of the intervention conditions on secondary behavioral outcomes (e.g., clinician-patient discussions about CRC screening) and on intermediate outcome measures of attitudes, beliefs, opinions, and social influence surrounding CRC screening among patients, clinicians, and clinical staff. The target population includes average-risk patients aged 50-75 years, clinicians, and clinical staff within the primary care setting. The intervention will be implemented within primary care clinics in two managed care organizations (MCOs). The intervention targets the following CRC screening modalities: fecal occult blood test (FOBT), flexible sigmoidoscopy, colonoscopy, and double contrast barium enema.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Usual care
  • Behavioral: Clinic-focused intervention
  • Behavioral: Clinic- and patient-focused
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
5066 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics
Study Start Date :
Jul 1, 2009
Actual Primary Completion Date :
Jun 1, 2010
Actual Study Completion Date :
Dec 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Other: 1

Usual care

Behavioral: Usual care
No intervention will be conducted in this arm of the study.

Experimental: 2

Clinic-focused intervention: The clinicians and clinical staff in each of the clinics will be scheduled for training sessions. The provider trainings will be designed for clinicians and clinical staff and will be conducted in at least two separate sessions of approximately 3 hours total duration. The sessions will be scheduled to accommodate the clinic schedule, but will be held with no more than 1 month between them. Participants in clinic training sessions will receive continuing education credit.

Behavioral: Clinic-focused intervention
The clinic-focused intervention consists of CRC screening training sessions for clinicians and clinical staff. The provider training sessions will include the presentation of CRC screening statistics and information, and will be heavily interactive and skills-based. The provider training sessions will also focus on the provision of tools for improving clinical staff- and clinician-patient interactions about CRC screening and for office system changes/improvements to identify eligible patients and to track screening.

Experimental: 3

Clinic-focused and patient focused intervention: The clinic focused-intervention as described in Arm 2 will be combined with a patient-focused intervention. Patient focused intervention: CRC education packets, based upon previously developed CDC CRC patient education materials, have been adapted for each study site. These CRC educational packets will be mailed to average-risk patients aged 50-80 years who are due for CRC screening (based on electronic records) and who schedule a non-acute ambulatory care visit in clinics assigned to the patient-focused intervention. A cover letter signed by the patient's physician will be included with each packet. The packets will be mailed approximately 1 week before the medical appointment.

Behavioral: Clinic- and patient-focused
This arm will combine the clinic-focused intervention and the patient-focused intervention. The clinic-focused intervention consists of CRC screening training sessions for clinicians and clinical staff as described in Arm 2. The patient-focused intervention includes sending a CRC screening education packet (CDC-developed educational text tailored for use within the study sites), accompanied by a letter from the patient's physician, to patients meeting study inclusion criteria.

Outcome Measures

Primary Outcome Measures

  1. Changes in colorectal cancer screening rates (4 modalities) [One year post initiation of intervention]

Secondary Outcome Measures

  1. Changes in the frequency of secondary behavioral outcomes (e.g., clinician-patient discussions about CRC screening) [One year post initiation in intervention]

  2. Changes in measures of attitudes, beliefs, opinions, and social influence surrounding CRC screening among patients, clinicians, and clinical staff. [One year post initiation of intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Inclusion Criteria for the Patient-focused Intervention

  • Average risk

  • Male or female

  • 50-75 years

  • Scheduled for non-acute ambulatory care visit at one of the study sites

  • Due for CRC screening including no record of FOBT in the past year, no record of flexible sigmoidoscopy in the past 5 years, no record of colonoscopy in the past 10 years, and no record of double contrast barium enema in the past 5 years

Inclusion Criteria for the Clinic-focused Intervention

  • Primary care clinicians, to include the following specialties: Family Practice/General Practice Physicians, General Internal Medicine Physicians, Nurse Practitioners in Family/General Practice, Physician Assistants who conduct non-acute ambulatory medical exams in study clinics

  • Primary care clinical staff, to include nurses, medical assistants, and appointment schedulers

Exclusion Criteria (Patients):
  • Prior diagnosis of CRC

  • Prior diagnosis of colorectal polyps

  • Prior diagnosis of ulcerative colitis

  • Prior diagnosis of Crohn's Disease

  • Prior diagnosis of hereditary nonpolyposis or polyposis

  • Medical records contain an International Classification of Diseases (ICD-9) code for family history of CRC

  • Younger than 50 years of age

  • Older than 80 years of age.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Henry Ford Health System Detroit Michigan United States 48202
2 ABQ Health Partners/Lovelace Clinic Foundation Albuquerque New Mexico United States 87106
3 Battelle Centers for Public Health Research and Evaluation Seattle Washington United States 98109

Sponsors and Collaborators

  • Centers for Disease Control and Prevention

Investigators

  • Principal Investigator: Judith Lee Smith, PhD, Centers for Disease Control and Prevention

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00737646
Other Study ID Numbers:
  • CDC-NCCDPHP-4555
First Posted:
Aug 19, 2008
Last Update Posted:
Dec 17, 2012
Last Verified:
Dec 1, 2012
Keywords provided by Centers for Disease Control and Prevention
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 17, 2012